FORSYTH DOUGLAS
SEC insider (Form 3/4/5 filer). CIK 0001240801. Director at Inhibrx Biosciences, Inc. (INBX). 3 reported Form 4/5 transactions since Sep 2024; latest on Sep 8, 2026. Located in LA JOLLA, CA.
Companies FORSYTH DOUGLAS has filed insider reports for
- Inhibrx Biosciences, Inc. (INBX): Director
FORSYTH DOUGLAS
CIK: 0001240801
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
INBX
Inhibrx Biosciences, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Sep 8, 2026INBX
Inhibrx Biosciences, Inc.
PurchaseIndirect2.5K shares at avg. $114.65$287K - Jun 3, 2026INBX
Inhibrx Biosciences, Inc.
AwardDirectStock Option (right to buy)
10K shares- - May 28, 2025INBX
Inhibrx Biosciences, Inc.
AwardDirectStock Option (right to buy)
15K shares-
1-3 of 3 transactions